Ethan Lippmann, assistant professor of chemical and biomolecular engineering at Vanderbilt University, has won an inaugural Chan Zuckerberg Initiative grant for neurodegenerative disorders research. The five-year, $2.5 million award supports his goal of better understanding how blood-brain barrier dysfunction impacts neurodegenerative diseases such as Alzheimer’s and Parkinson’s.
Today, the Chan Zuckerberg Initiative announced a total of $64.25 million in awards and its selection of 17 early career investigators and nine collaborative science teams to launch the CZI Neurodegeneration Challenge Network. Facebook CEO Mark Zuckerberg and pediatrician Priscilla Chan launched the Chan Zuckerberg Initiative in December 2015.
The new network will bring together scientists, physicians and engineers to focus on neurodegenerative diseases as a broad class of disorders with shared features and potentially shared solutions. Network researchers will focus on understanding the fundamental biology of what causes these diseases and how they progress, with an aim toward future development of new strategies for treatment and prevention.